SimBioSys Unveils TumorSight Viz 1.4, Adding AI‑Powered Surgical Outcome Visualization
SimBioSys rolls out the latest version of its FDA‑cleared TumorSight Viz platform at the ASBrS Annual Meeting, introducing a new surgical outcome visualization module that promises to reshape pre‑operative planning for breast cancer surgeons. At the American Society of Breast Surgeons (ASBrS) conference in Seattle, SimBioSys introduced TumorSight Viz 1.4, an upgraded version of its AI‑driven 3‑D breast‑MRI…
